Researchers discovered a mechanism that stops the body reacting with an excessive immune reaction. This could be the basis for a new treatment.
Most people with allergies have to take medication throughout their life: Their body “thinks” that proteins from the environment are so “strange” that they elicit an immune reaction. Until present, it was not possible to develop an efficient therapy so that the body “learns” to stop in an overreacting way.
Scientists from the Swiss Institute of Allergy and Asthma Research (SIAF) in Davos, from the University of Tokyo, the RIKEN Research Institute in Yokohoma, and from Stanford University recently discovered a mechanism that could be the basis for a new way to handle allergies.
Mast cells play a key role in the disease process in allergies: As a reaction towards an allergen – for example pollen or dust mites – they release big amounts of substances that initiate an inflammatory process. Study leader Hideaki Morita and his team discovered that mast cells are not only “bad guys”, but also have a “good side” (see figure): They release the substance interleukin-2 that induces the production of certain immune cells called T-regulatory (Treg) cells. Treg cells can suppress the allergic inflammatory process in the airways induced by interleukin-10.
It is already known for some time that Treg cells can subdue an excessive immune response and the resulting inflammation. For example, injections with Treg cells prevented autoimmune diseases in mice. However, for Treg cell treatments one needs a large amount of these cells, which is not easy to realise. In the blood, there are just a few of them, and in vitro they are difficult to produce. Using mast cells, Treg cells could be easily produced in the laboratory in large quantities.
“The mechanism that we discovered, could be the basis for a new way to handle allergies,” says Hideaki Morita.
Read more: A possible cure for allergies
The Latest on: Cure for allergies
via Google News
The Latest on: Cure for allergies
- FDA approves first peanut allergy drug treatmenton February 3, 2020 at 3:22 pm
It’s called Palforzia, and it’s targeted to kids ages 4 through 17 with confirmed peanut allergies. The treatment, which is made from peanuts will not allow the patients to actually eat peanuts. They ...
- The FDA Approved the First Treatment for Peanut Allergies in Childrenon February 3, 2020 at 2:21 pm
“Peanut allergy affects approximately one million children in the U.S. and only one out of five of these children will outgrow their allergy. Because there is no cure, allergic individuals must ...
- The First Peanut Allergy Treatment Has Been Approved By FDAon February 3, 2020 at 1:43 pm
The Food and Drug Administration has approved the first treatment for peanut allergies, and doctors may begin prescribing it within the next few weeks. The treatment will provide families with a new ...
- Peanut allergy treatment 'just the beginning' for Aimmune, the company who invented it, CEO sayson February 3, 2020 at 11:29 am
Aimmune Therapeutics (AIMT), which on Friday received U.S. Food and Drug Administration approval for its peanut allergy treatment that’s billed as the first of its kind, is already pursuing an ...
- FDA approves first drug for peanut allergy in childrenon February 3, 2020 at 10:41 am
Palforzia, a powder manufactured from peanuts, is indicated for initiation in individuals aged 4 to 17 years old with a confirmed peanut allergy. Treatment may be continued in individuals aged 4 years ...
- First Drug Approved for Treatment of Peanut Allergy in Childrenon February 3, 2020 at 10:01 am
MONDAY, Feb. 3, 2020 (HealthDay News) -- The U.S. Food and Drug Administration approved Palforzia (Peanut [Arachis hypogaea] Allergen Powder-dnfp) to alleviate allergic reactions to accidental peanut ...
- FDA clears the first treatment for kids with peanut allergyon February 3, 2020 at 7:48 am
The FDA cleared the drug Palforzia; it is the first peanut allergy drug that is safe for kids. Dr. Jayson Dallas, Aimmune Therapeutics CEO & President shares the details with Yahoo Finance's On The ...
- First Treatment for Peanut Allergy Approved by FDAon February 3, 2020 at 7:17 am
Feb. 3, 2020 -- The first treatment for peanut allergy has been approved by the U.S. Food and Drug Administration. Palforzia is not a cure, youngsters using the treatment still must avoid peanuts, and ...
- A little-known biopharma firm surges 17% after getting FDA approval for the first-ever peanut allergy treatmenton February 3, 2020 at 7:02 am
Shares jumped as much as 17% on Monday after news Friday that the FDA had approved Aimmune's new drug.
- Treatment approved for peanut allergieson February 2, 2020 at 4:26 pm
WASHINGTON - The first treatment for peanut allergies is about to hit the market, a big step toward better care for all kinds of food allergies - but still a long way from a cure. The approval by the ...
via Bing News